Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Maraskovsky

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Science (New York, N.Y.)|December 5, 1998
Developmental optionsK Shortman, E Maraskovsky
Journal of Immunology (Baltimore, Md. : 1950)|August 15, 1989
IL-2 and IFN-gamma are two necessary lymphokines in the development of cytolytic T cellsE Maraskovsky, W F Chen, K Shortman
International Immunology|April 1, 1992
Co-engagement of CD3 with LFA-1 or ICAM-1 adhesion molecules enhances the frequency of activation of single murine CD4+ and CD8+ T cells and induces synthesis of IL-3 and IFN-gamma but not IL-4 or IL-6E Maraskovsky, A B Troutt, A Kelso
Trends in Immunology|April 5, 2001
Modulating the immune response with dendritic cells and their growth factorsB Pulendran, J Banchereau, E Maraskovsky, et al.
International Immunology|March 1, 1991
High-frequency activation of single CD4+ and CD8+ T cells to proliferate and secrete cytokines using anti-receptor antibodies and IL-2(1)E Maraskovsky, M H Pech, A Kelso
The Lancet. Oncology|March 22, 2002
The use of dendritic cells in cancer therapyM Jefford, E Maraskovsky, J Cebon, et al.
Cellular Immunology|April 15, 1992
Murine cytolytic CD8+ T cell clones generated in a high cloning efficiency, accessory cell-free culture system express a restricted lymphokine profileE Maraskovsky, L A Rogers, A B Troutt, et al.
International Immunology|October 24, 1998
Overexpression of Bcl-2 does not rescue impaired B lymphopoiesis in IL-7 receptor-deficient mice but can enhance survival of mature B cellsE Maraskovsky, J J Peschon, H McKenna, et al.
The Journal of Experimental Medicine|December 8, 1998
Prevention of peripheral tolerance by a dendritic cell growth factor: flt3 ligand as an adjuvantB Pulendran, J L Smith, M Jenkins, et al.
Immunology and Cell Biology|February 1, 1992
Quantitative analysis of lymphokine expression in vivo and in vitroA B Troutt, E Maraskovsky, L A Rogers, et al.
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Science (New York, N.Y.)|December 5, 1998
Developmental optionsK Shortman, E Maraskovsky
Journal of Immunology (Baltimore, Md. : 1950)|August 15, 1989
IL-2 and IFN-gamma are two necessary lymphokines in the development of cytolytic T cellsE Maraskovsky, W F Chen, K Shortman
International Immunology|April 1, 1992
Co-engagement of CD3 with LFA-1 or ICAM-1 adhesion molecules enhances the frequency of activation of single murine CD4+ and CD8+ T cells and induces synthesis of IL-3 and IFN-gamma but not IL-4 or IL-6E Maraskovsky, A B Troutt, A Kelso
Trends in Immunology|April 5, 2001
Modulating the immune response with dendritic cells and their growth factorsB Pulendran, J Banchereau, E Maraskovsky, et al.
International Immunology|March 1, 1991
High-frequency activation of single CD4+ and CD8+ T cells to proliferate and secrete cytokines using anti-receptor antibodies and IL-2(1)E Maraskovsky, M H Pech, A Kelso
The Lancet. Oncology|March 22, 2002
The use of dendritic cells in cancer therapyM Jefford, E Maraskovsky, J Cebon, et al.
Cellular Immunology|April 15, 1992
Murine cytolytic CD8+ T cell clones generated in a high cloning efficiency, accessory cell-free culture system express a restricted lymphokine profileE Maraskovsky, L A Rogers, A B Troutt, et al.
International Immunology|October 24, 1998
Overexpression of Bcl-2 does not rescue impaired B lymphopoiesis in IL-7 receptor-deficient mice but can enhance survival of mature B cellsE Maraskovsky, J J Peschon, H McKenna, et al.
The Journal of Experimental Medicine|December 8, 1998
Prevention of peripheral tolerance by a dendritic cell growth factor: flt3 ligand as an adjuvantB Pulendran, J L Smith, M Jenkins, et al.
Immunology and Cell Biology|February 1, 1992
Quantitative analysis of lymphokine expression in vivo and in vitroA B Troutt, E Maraskovsky, L A Rogers, et al.
Pageof 4